Skip to Content


In the US, Valcyte (valganciclovir systemic) is a member of the drug class purine nucleosides and is used to treat CMV Retinitis and Cytomegalovirus Infection.

US matches:

UK matches:

Ingredient matches for Valcyte


Valganciclovir is reported as an ingredient of Valcyte in the following countries:

  • Egypt
  • Georgia
  • Israel
  • Lebanon
  • Poland
  • Turkey

Valganciclovir hydrochloride (a derivative of Valganciclovir) is reported as an ingredient of Valcyte in the following countries:

  • Armenia
  • Australia
  • Austria
  • Belgium
  • Bulgaria
  • Canada
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Mexico
  • Moldova
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Romania
  • Russian Federation
  • Serbia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Thailand
  • United Kingdom
  • United States

← International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.